Idursulfase

In the US, Idursulfase (idursulfase systemic) is a member of the drug class lysosomal enzymes and is used to treat Mucopolysaccharidosis Type II.

US matches:

• Idursulfase


• Idursulfase Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A16AB09

CAS registry number (Chemical Abstracts Service)

0050936-59-9

Chemical Formula

C2689-H4057-N699-O792-S14

Molecular Weight

59297

Therapeutic Category

Enzyme

Chemical Names

α-L-iduronate sulfate sulfatase (WHO)

Sulfatase, L-idurono- (USAN)

Foreign Names

• Idursulfaseum (Latin)
• Idursulfase (German)
• Idursulfase (French)
• Idursulfasa (Spanish)

Generic Names

• Idursulfase (OS: BAN, USAN)
• EC 3.1.6.13 (IS: TranskaryoticT)
• I2S (IS: Shire)
• I2S CNS (IS)
• Idusulfase (IS)
• Sulfoiduronate sulfohydrolase (IS)

Brand Names

• Elaprase
  Drac, Switzerland; LCA, Belgium; Paladin, Canada; Shire, Austria; Shire, France; Shire, Greece; Shire, Netherlands; Shire, United States; Shire HGT, Germany; Shire Human, Spain; Shire Human, Sweden; Shire Human Genetic, United Kingdom; Shire Human Genetic Therapies, Denmark; Shire Human Genetic Therapies, Finland; Solpharm, Croatia (Hrvatska)

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.